N@N

Market Maker Surveillance Report. EDAP, SYMX, RAME, VRUS, NBS, QBC, Winning Stocks With Lowest Price Friction For Monday, Marc

March 7, 2011 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 2381 companies with "abnormal" market making, 1404 companies with positive Friction Factors and 3970 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Monday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. EDAP TMS SA -ADR (NASDAQ:EDAP), SYNTHESIS ENERGY SYSTEMS INC (NASDAQ:SYMX), RAM ENERGY RESOURCES INC (NASDAQ:RAME), PHARMASSET INC (NASDAQ:VRUS), NEOSTEM INC (AMEX:NBS), CUBIC ENERGY INC (AMEX:QBC). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

     Symbol     Change       Percent      Buy Volume      Buy %%       Sell Volume     Sell %%      Net Volume      Friction
     EDAP       $1.160       32.40%       419,215         58.10%       297,310         41.21%       121,905         1,051   
     SYMX       $0.640       47.06%       2,459,794       50.62%       2,389,813       49.18%       69,981          1,093   
     RAME       $0.440       21.78%       7,989,857       51.44%       7,536,930       48.53%       452,927         10,294  
     VRUS       $12.180      24.47%       1,426,681       52.88%       1,248,897       46.29%       177,784         146     
     NBS        $0.260       17.45%       624,575         54.18%       476,481         41.33%       148,094         5,696   
     QBC        $0.140       16.11%       1,044,265       50.93%       873,681         42.61%       170,584         12,185  

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows EDAP with a dollar gain Monday of $1.16000 and a Friction Factor of 1,051 shares. That means that it only took 1,051 more shares of buying than selling to move EDAP higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

EDAP TMS SA -ADR (NASDAQ:EDAP) - EDAP TMS S.A. and its subsidiaries develop, produce, market, distribute, and maintain medical devices for the treatment of urological diseases. It operates in two divisions, High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of certain types of localized tumors using HIFU technology. The HIFU technology enables a surgeon to destroy a defined area of diseased tissue without damaging surrounding tissue and organs. This division offers Ablatherm, an ultrasound guided HIFU device for the treatment of organ-confined prostate cancer. The UDS division produces and markets lithotripters devices for the treatment of urinary tract stones by using ESWL technology. This division manufactures three models of lithotripters: the Sonolith Praktis, the Sonolith Vision, and the Sonolith I-Sys. It also involves in leasing lithotripters, as well as offers disposables, spare parts, and maintenance services. EDAP TMS S.A. serves public and private hospitals, urology clinics, and research institutions. It markets and sells its products through direct marketing, service platform, and sales organization, as well as through third-party distributors and agents worldwide. The company was founded in 1979 and is based in Vaulx-en-Velin, France.

SYNTHESIS ENERGY SYSTEMS INC (NASDAQ:SYMX) - Synthesis Energy Systems, Inc., a development stage company, focuses on developing and commercializing gasification technology primarily in China and the United States. The company intends to build, own, and operate coal gasification plants that utilize its proprietary U-GAS fluidized bed gasification technology to convert low rank coal and coal wastes into higher value energy products, such as transportation fuels and ammonia. Synthesis Energy Systems was founded in 2003 and is headquartered in Houston, Texas.

RAM ENERGY RESOURCES INC (NASDAQ:RAME) - RAM Energy Resources, Inc., an independent oil and natural gas company, engages in the acquisition, development, exploitation, exploration, and production of oil and natural gas properties primarily in Texas, Louisiana, Oklahoma, New Mexico, and West Virginia. The company operates in the upstream segment of the oil and gas industry with activities, including the drilling, completion, and operation of oil and gas wells. As of December 31, 2009, RAM Energy Resources, Inc. had estimated net proved reserves of approximately 33.9 million barrels of oil equivalent, which includes crude oil, natural gas, and natural gas liquids. The company was founded in 1987 and is based in Tulsa, Oklahoma.

PHARMASSET INC (NASDAQ:VRUS) - Pharmasset, Inc., a clinical-stage pharmaceutical company, focuses on discovering, developing, and commercializing novel drugs to treat viral infections. Its primary focus is on the development of nucleoside/tide analogs as oral therapeutics for the treatment of chronic hepatitis C virus (HCV) infection; and Racivir for the treatment of human immunodeficiency virus (HIV) infection. The company has three product candidates under development, which include RG7128, a HCV nucleoside polymerase inhibitor that is in Phase IIb clinical trial; PSI-7851, a HCV nucleotide polymerase inhibitor that completed Phase I clinical trial; and Racivir, which completed Phase II clinical trial, for the treatment of HIV. It has strategic collaboration agreement with F. Hoffmann-LaRoche Ltd. and Hoffmann-La Roche Inc. for the development of PSI-6130 and its products, including RG7128. The company also has collaboration and licensing agreements with University of Cincinnati; Apath, LLC; Emory University; Bukwang Pharm. Co., Ltd; University of Georgia Research Foundation, Inc. and Yale University; and Boehringer Ingelheim Chemicals, Inc. Pharmasset, Inc. was founded in 1998 and is based in Princeton, New Jersey.

NEOSTEM INC (AMEX:NBS) - NeoStem, Inc. engages in the development of stem cell-based therapies for anti-aging initiatives and building a network of adult stem cell collection centers in the United States and China. It provides adult stem cell collection, processing, and storage services enabling healthy individuals to donate and store their stem cells for personal therapeutic use. The company also focuses on developing a pipeline of regenerative medicine therapies focused on orthopedic conditions; developing wellness, cosmetic, and anti-aging applications; and participating in the medical tourism market for regenerative medical treatments. In addition, it offers anti-infective drugs that include active pharmaceutical ingredients (API) under Acetylspiramycin and Oxacillin Sodium names; and injectible finished products under Mezlocillin Sodium, Amoxicillin/Sulbactum Sodium, and Cefoperazone/Sulbactum Sodium names. It sells its prescriptive drugs and APIs through hospitals in China. NeoStem, Inc. has a collaborative agreement with ImmuneRegen BioSciences, Inc. that focuses on the development of an advanced, adult human stem cell product; and with Enhance Biomedical Holding Corporation for the development of an adult stem cell collection and treatment network. The company was founded in 1980 and is headquartered in New York, New York.

CUBIC ENERGY INC (AMEX:QBC) - Cubic Energy, Inc., an independent energy company, engages in the exploration, development, and production of crude oil, natural gas, and natural gas liquids primarily in Texas and Louisiana. The companys Texas properties are located in Palo Pinto, Eastland, and Callahan Counties; and Louisiana properties are situated in Caddo Parish and in Desoto Parish. As of June 30, 2009, it had total proved reserves of approximately 21,076,880 thousand cubic feet of natural gas equivalent. The company was founded in 1978 and is based in Dallas, Texas.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net